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Relationship between gastro-intestinal
complaints and endotoxaemia, cytokine release
and the acute-phase reaction during and after a
long-distance triathlon in highly trained men
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W. H. M. SARIS* and A. J. M. WAGENMAKERS*
*Department of Human Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands, and
†Department of Clinical Chemistry, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
A B S T R A C T
The aim of the present study was to establish whether gastro-intestinal (GI) complaints observed
during and after ultra-endurance exercise are related to gut ischaemia-associated leakage of
endotoxins [lipopolysaccharide (LPS)] into the circulation and associated cytokine production.
Therefore we collected blood samples from 29 athletes before, immediately after, and 1, 2 and
16 h after a long-distance triathlon for measurement of LPS, tumour necrosis factor-a
and interleukin-6 (IL-6). As the cytokine response would trigger an acute-phase response,
characteristic variables of these responses were also measured, along with creatine kinase (CK)
to obtain an indicator of muscle damage. There was a high incidence (93% of all participants) of
GI symptoms; 45% reported severe complaints and 7% of the participants abandoned the race
because of severe GI distress. Mild endotoxaemia (5–15 pg/ml) was evident in 68% of the athletes
immediately after the race, as also indicated by a reduction in IgG anti-LPS levels. In addition, we
observed production of IL-6 (27–fold increase immediately after the race), leading to an acute-
phase response (20-fold increase in C-reactive protein and 12% decrease in pre-albumin 16 h after
the race). The extent of endotoxaemia was not correlated with the GI complaints or the IL-6
response, but did show a correlation with the elevation in C-reactive protein (rs 0.389;
Pfl 0.037). Creatine kinase levels were increased significantly immediately post-race, and
increased further in the follow-up period. Creatine kinase levels did not correlate with those of
either IL-6 or C-reactive protein. It is therefore concluded that LPS does enter the circulation
after ultra-endurance exercise and may, together with muscle damage, be responsible for the
increased cytokine response and hence GI complaints in these athletes.
INTRODUCTION
Prolonged exercise at high intensity leads to a quantitative
redistribution of blood flow, i.e. flow to the exercising
muscles is increased in order to supply oxygen and
substrates. In addition, during intense exercise the blood
flow to the skin is increased to facilitate heat dissipation.
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Abbreviations : CK, creatine kinase ; CRP, C-reactive protein ; GI, gastro-intestinal ; IL-6, interleukin-6; LAL, Limulus amoebocyte
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As a consequence, blood flow to central tissues (gut and
liver) is reduced during exercise [1,2]. During maximal
exercise in humans, blood flow to the gut is reduced by
about 80% [3]. Exercise in the heat leads to an extra loss
of total body water and a greater decrease in plasma
volume, with further reduction in blood flow to the gut
[4,5]. A similar redistribution of blood flow is seen in
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patients with major trauma and}or sepsis and various
forms of shock [6]. In this situation, a serious underper-
fusion of the gut often leads to shock-induced mucosal
damage and invasion of Gram-negative intestinal bacteria
and}or their toxic constituents (endotoxins) into the
blood circulation [7]. Endotoxins are highly toxic lipo-
polysaccharides (LPS) of the outer cell wall of Gram-
negative bacteria. Increased circulating LPS levels in
patients lead to various symptoms, such as fever,
shivering, dizziness, nausea, various gastro-intestinal
(GI) complaints such as vomiting and diarrhoea, and
ultimately sepsis [8]. Such symptoms are also frequently
reported by ultra-endurance athletes, in particular GI
problems such as stomach cramps or stomach ache,
intestinal cramps and diarrhoea [9–11]. The prevalence
of such symptoms has been reported to be 30–50%
among marathon runners [12–14]. Marathon runners
occasionally develop serious gut complaints (blood loss
in the faeces) in the hours following a marathon, which
may be due to increased intestinal permeability [15].
Despite their high prevalence, the aetiology of these GI
complaints in endurance athletes is still incompletely
understood.
Not only might decreased splanchnic blood flow lead
to ischaemic damage to the intestinal wall, but there may
also be thermal and mechanical damage to the mucosal
layer of the gut. Gram-negative bacteria, present in the
gut, may then penetrate the mucosal layer and enter
the lymph nodes in the submucosal tissues. This may lead
to the entry of LPS into the portal vein and, under ex-
treme conditions, even into the main circulation. Indeed,
endotoxaemia after strenuous ultra-endurance exercise
has been reported in some studies [16–18], although this
finding was not consistent [19–21].
LPS are a major trigger in vivo for the host immune
response via induction of the cytokine network. The
cytokine tumour necrosis factor-a (TNF-a) is presumed
to be the central inflammatory mediator [22]. TNF-a is
produced by macrophages and monocytes. It stimulates
the production of other cytokines by monocytes and
other cells, including endothelial cells. Other pro-inflam-
matory cytokines include interleukin-1 (IL-1) and IL-6
[23]. TNF-a, IL-1 and IL-6 have many biological effects,
including the triggering of the acute-phase response
[24,25]. This involves substantial changes in the plasma
concentrations of many proteins in response to bodily
harm, e.g. an increased inflammatory or surgical situ-
ation. Both increases and decreases in plasma protein
concentrations, the so-called positive and negative acute-
phase responses, occur due to changes in their rate of
synthesis in the liver. IL-6 induces the full spectrum
of the acute-phase reaction, whereas IL-1 and TNF-a
lead to only a partial reaction [24,25]. Pre-albumin and
C-reactive protein (CRP) are good examples of negative
and positive acute-phase reactants respectively.
The first aim of the present study was to investigate
whether endotoxaemia occurs in the 16 h after a long-
distance triathlon. We also measured IgG anti-LPS
antibody concentrations as an indicator of LPS leakage,
as such antibodies are expected to decrease over a more
prolonged time period than potential LPS appearance in
the circulation, due to the formation and subsequent
clearance of LPS–anti-LPS complexes. Furthermore,
decreases in anti-LPS may also be seen when LPS is
produced only locally (e.g. in the gut and portal vein), i.e.
without appearing in the systemic circulation. We also
measured the cytokines TNF-a and IL-6 as possible
mediators of LPS-induced effects, and CRP and pre-
albumin as indicators of the acute-phase reaction. A
second aim of our investigation was to study the
relationship between GI complaints and the measured
indirect markers of the gut barrier function: endo-
toxaemia, the cytokines and the acute-phase response. In
order to study the effects of extreme exercise, we chose a
long-distance triathlon (3.8 km swimming, 185 km
cycling and 42.2 km running) in Embrun, France. This
triathlon is believed to be one of the most challenging
world-wide. The conditions of this race are extreme (high
temperatures, altitude, long duration), and thus the
prevalence of GI symptoms and possibly endotoxaemia
was expected to be high.
METHODS
Subjects and protocol
In total, 29 male triathletes and one female triathlete were
recruited for the study. All subjects were instructed and
informed about the procedures of the study, and signed a
consent form. Subjects’ age and weight was 33.0‡6.0
years and 72.3‡7.3 kg respectively. The Ironman dis-
tance triathlon in Embrun (Embrunman) in France, held
on 15th August 1996, was chosen because this is supposed
to be one of the most challenging long-distance triathlons.
After the swim (3800 m) in open water, athletes cycled a
course of 185 km in the mountains (Alps) with an altitude
difference of 3600 m. Subsequently the athletes ran
42.2 km, partly on unpaved roads. The temperature was
9.4 °C in the morning at the start (6.00 hours), with a high
of 32.1 °C around 14.00 hours. The water temperature
was 18.6 °C at the start.
Questionnaire
A questionnaire (20 items) was provided 2 or 3 days
before the race containing questions regarding training
background, performance level, experience, preparation
and the use of supplements. A second questionnaire (96
items) was provided directly after the race, and athletes
were asked to complete this within 2 h after finishing.
This second questionnaire contained questions regarding
the occurrence of GI symptoms during swimming,
cycling and running, and in the 1 h after the race. In case
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subjects abandoned the race, questions were included to
obtain the reason for abandoning.
Body mass and fluid balance
Weight was recorded on the day before the triathlon, 1 h
before the start and immediately after the race. Subjects
were carefully instructed to report fluid and solid food
intake during the race as accurately as possible. Fluid in-
take was estimated from the reported beverage (and
solid food) intake. Immediately after the race, athletes
were also asked to write down as accurately as possible
what beverages and solid food they had consumed during
the race, and in what amounts. The nutritional com-
position of the dietary intake during the race was
calculated through information from producers of par-
ticular products or from the Dutch Nutritional (NEVO)
tables. Fluid loss was estimated from weight loss and
corrected for fluid intake.
Blood collection and analyses
Blood samples were collected on the day before the race,
immediately after the finish of the race, and 1 h, 2 h and
15–20 h after the finish. The blood was used for the
measurement of LPS, anti-LPS, TNF-a, IL-6, CRP and
pre-albumin. At each time point three samples of 4.0 ml
of heparin-anticoagulated blood were collected (Endo
Tube; Chromogenix AB, Mo$ lndahl, Sweden), along with
5.0 ml of non-anticoagulated blood. The tubes with the
heparinized blood were immediately placed on melting
ice. One was centrifuged at 180 g and 4 °C for 10 min to
prepare platelet-rich plasma for the LPS assays. These
samples were divided into two aliquots and stored at
fi20 °C. The two other tubes were centrifuged at 3000 g
and 4 °C for 10 min to prepare platelet-poor plasma for
the TNF-a and IL-6 assays. The platelet-poor plasma
was divided into 500 ll aliquots. The 5 ml non-anti-
coagulated blood sample was allowed to clot for at least
30 min at ambient temperature to prepare serum, centri-
fuged at 3000 g at 4 °C for 10 min, and aliquots of 500 ll
were stored at fi20 °C. The serum was used for the anti-
LPS, pre-albumin and CRP assays.
Blood was also collected from 20 healthy untrained
male volunteers (mean age 38 years ; range 20–55 years) to
determine reference ranges of anti-LPS, IL-6, pre-
albumin and CRP. The reference ranges were determined
in male volunteers because 29 of the 30 athletes were also
male. All results were corrected for fluid shifts.
LPS
LPS was assayed using chromogenic assays obtained
from Boehringer Ingelheim Whittaker, Verviers, France
(the b-glucan-insensitive LPS assay) and Chromogenix
AM, Mo$ lndal, Sweden (the more b-glucan-sensitive LPS
assay), as described previously [26–28]. A b-glucan-
sensitive LPS assay was used in addition to a b-
glucan-insensitive LPS assay in order to detect the
presence of fungi. b-Glucan is present in fungi and
would therefore be detected with the b-glucan-sensitive
assay, but not with the b-glucan-insensitive LPS assay.
Also, there is controversy in the literature as to whether
endotoxaemia does occur after exercise, and we therefore
decided to use two assays from independent companies.
Briefly, the platelet-rich plasma samples were thawed
for 5 min at 37 °C, diluted 10-fold with pyrogen-free
water and heated for 15 min at 75 °C to remove inhibitory
activity from the plasma. After cooling to room tem-
perature for 1 h, 50 ll aliquots were transferred to a
microtitre plate. After incubation at 37 °C with 50 ll of
LAL (Limulus amoebocyte lysate) reagent (Biowhittaker
30 min; Chromogenix 12 min) and the subsequent
chromogenic substrate (Biowhittaker 6 min; Chromo-
genix 8 min), the reaction was stopped with acetic acid
and the yellow colour read at 405 nm. Readings were
compared with a standard curve prepared in human
platelet-rich plasma with the Escherichia coli 0111:B4
standard provided by the manufacturers according to
the same procedure and prepared simultaneously with the
test samples. With this standard, 1.2 endotoxin units}ml
corresponds to approx. 120 pg}ml.
IgG anti-LPS
IgG anti-LPS was assayed by ELISA with reagents
(Endocab) that were kindly provided by Chromogenix
AB. Briefly, serum samples were thawed at room
temperature and diluted 200-fold in the sample buffer
provided in the kit. Then 100 ll of this diluted sample or
standard was added to a microtitre plate, which had been
precoated with a mixture of LPS by the manufacturer.
After incubation at 37 °C for 60 min to bind the anti-LPS
antibodies in the serum to the plate, the plate was washed
three times with wash buffer. Then 100 ll of an antibody
to human IgG was added, which had been conjugated to
alkaline phosphatase. After incubation for 60 min at
37 °C, the plate was washed three times with wash buffer
and five times with distilled water. Then 100 ll of a
freshly prepared substrate solution of 800 lM p-
nitrophenyl phosphate was added; the incubation was
continued for 60 min at ambient temperature in the dark,
and then the reaction was stopped by the addition of
50 ll of 3 M H
#
SO
%
and the absorbance was read at
405 nm. Endocab is expressed in median units}ml, i.e. the
median level observed in a group of 100 volunteers tested
by the manufacturer.
TNF-a and IL-6
In the assays for TNF-a and IL-6, Endo tube ET col-
lection tubes were used to avoid any contamination with
LPS and thus to avoid higher levels of TNF-a and IL-6
due to in vitro activation of blood cells. TNF-a and
IL-6 were determined by ELISA (Pelikine Compact2
TNF-a and IL-6 ELISA kits ; Central Laboratory of the
Netherlands Red Cross Blood Transfusion Service).
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CRP
CRP was determined by nephelometry on an Hitachi 911
analyser (Boehringer Mannheim, Mannheim, Germany)
with reagents and according to the instructions provided
by this supplier.
Pre-albumin
Pre-albumin was determined by nephelometry on an
auto-analyser (ARRAY; Beckman Instruments Inc.,
Breda, The Netherlands), with reagents and according to
the instructions provided by this supplier.
Creatine kinase (CK)
CK was determined by spectrophotometry on an Hitachi
747 analyser (Boehringer Mannheim) with the N-
acetylcysteine-activated CK reagent kit and according to
the instructions provided by this supplier.
Statistics
GI symptoms were divided into two categories : severe
symptoms and less severe symptoms. Severe symptoms
included nausea, urge to vomit, vomiting, stomach ache
and intestinal cramps. Nausea, stomach ache, intestinal
cramps and urge to vomit were only registered as severe
symptoms when a score of 5 or higher out of 10 was
given. Less severe symptoms included eructation,
flatulence, urge to defecate, heartburn and abdominal
pressure (bloating). Nausea, stomach ache, intestinal
cramps and urge to vomit were registered as non-severe
symptoms when a score below 5 was given.
Symptoms reported during cycling and running were
compared with LPS and anti-LPS concentrations, as well
as with the parameters of the cytokine and acute-phase
response, using a Spearman Rank Correlation test. GI
complaints reported during swimming were ignored
because it is unlikely that these complaints would be
related to endotoxaemia.
A one-way analysis of variance was used to detect
changes over time. In cases of a significance, the difference
was located with a Tukey post-hoc test. To study
differences in measured blood parameters between the
triathletes and untrained healthy control subjects, an
unpaired t-test was applied. In all cases the level of
significance was set at P ! 0.05, and all results are
expressed as means‡S.E.M.
RESULTS
Study group
Because of incomplete data collection, the results from
one subject were discarded. Four out of the remaining 29
participants abandoned the race (14%). The reasons for
abandoning varied among athletes. Two of them could
not continue because of GI problems, and two abandoned
Table 1 GI and related complaints during the triathlon
Nausea, stomach ache, intestinal cramps and urge to vomit were only registered
when a score of 5 or higher (out of 10) was given.
Complaint n %
Stomach problems 9 31
Nausea 6 21
Dizziness 2 7
Headache 3 10
Flatulence 11 38
Urge to urinate 19 66
Urge to defecate 4 14
Belching 10 35
Heartburn 2 7
Bloating 7 24
Stomach cramps 3 10
Intestinal cramps 4 14
Urge to vomit 6 21
Vomiting 6 21
Diarrhoea 2 7
Side ache left 1 3
Side ache right 3 10
Muscle cramps 6 21
Cold shivering 3 10
because of muscle cramping and muscle soreness or
lower back problems.
GI complaints
The vast majority of the subjects (93%) reported some
GI symptoms, most of them being non-severe. The most
frequently reported complaints were flatulence and
eructation. There was also a relatively high prevalence of
severe symptoms (Table 1). Six subjects (21%) reported
an urge to vomit during either cycling or running, and
these subjects also vomited. One athlete during cycling
and one during running reported diarrhoea. Two athletes
abandoned the race because of severe GI problems,
including diarrhoea, stomach cramping, vomiting and
nausea.
Assays
The mean LPS concentration, as measured with the b-
glucan-insensitive assay, showed an increase immediately
post-exercise, and this increase was more pronounced 1 h
after the race (Figure 1). The highest measured value was
15.0 pg}ml. If it is assumed that endotoxaemia is present
at LPS concentrations of " 5.0 pg}ml [17,21] then, at 1 h
after the race, 68% of the athletes had endotoxaemia. At
2 h after the race only 19% of the athletes had endo-
toxaemia, but this proportion was increased again 16 h
after the race (79%). With the b-glucan-sensitive assay a
similar pattern in the LPS concentrations was observed,
but the highest level of LPS-active material was measured
immediately after the race. IgG anti-LPS levels had not
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Figure 1 LPS levels and IgG anti-LPS levels before and at several time points after the triathlon
LPS levels were measured both with a b-glucan-insensitive assay (left panel) and with a more b-glucan-sensitive assay (middle panel). The right panel depicts anti-
LPS levels in median units (MU)/ml. Values are means‡S.E.M. A significant elevation compared with the pre-race value is indicated by : aP! 0.05.
Figure 2 Concentrations of IL-6, TNF-a, CRP and pre-
albumin before and at several time points after the triathlon
CRP and pre-albumin represent positive and negative acute-phase proteins
respectively. Values are means‡S.E.M. Significant changes compared with pre-
race values are indicated by aP! 0.05 ; significant changes compared to 2 h after
the race are indicated by bP! 0.05.
changed directly or 1 h after the race, but showed a
tendency to decline after 2 h. After 16 h anti-LPS had
declined significantly compared with the levels at rest and
during the first 2 h after completion of exercise.
The concentrations of TNF-a, IL-6, CRP and pre-
albumin are presented in Figure 2. The TNF-a con-
centration was 0.84‡0.20 pg}ml before the race, and this
did not change significantly at any of the study periods.
The IL-6 concentration showed a significant average
27-fold increase immediately after the race, and then
Table 2 Correlations between changes in CRP, IL-6 and pre-
albumin levels and GI complaints
The presented values are Spearman rank correlation coefficients (rs) ; significance
is indicated by : *P ! 0.05 ; **P ! 0.01. The changes (D) in CRP, IL-6 and pre-
albumin levels were expressed as the change for each athlete between the value
at rest (before the race) and the value at the time of maximum response (for IL-
6 immediately after the race ; for CRP and pre-albumin 16 h after the race).
rs
GI complaint DIL-6 DCRP DPre-albumin
Nausea 0.155 0.259 0.223
Dizziness 0.264 0.350 0.503*
Intestinal cramps 0.174 0.397* 0.533**
Vomiting 0.268* 0.381 0.165
Diarrhoea 0.504* 0.511* 0.529*
decreased slowly. On the day after the race (16 h), IL-
6 had returned to pre-race levels. The CRP concentration
was elevated 2 h after the race compared with at rest
(1.53‡0.11 lg}ml), and was increased on average by 20-
fold 16 h after the race to a value of 30.2‡3.0 lg}ml. One
subject had a CRP concentration of 62.4 lg}ml. The pre-
albumin concentration was slightly elevated immediately
after the race and started to decrease in the hour after the
race. At 16 h after the race the pre-albumin concentration
was significantly lower than the concentration on the day
of the race.
Increases in LPS and IgG anti-LPS were not correlated
with any of the GI symptoms reported during running
and cycling (results not shown). The change in IL-6
concentration from rest to directly after the race showed
a significant correlation with vomiting and diarrhoea
during running (Table 2). Markers of the acute-phase
response (CRP and pre-albumin) also showed a
significant correlation with the incidence of diarrhoea
during running. Additionally, these two markers of the
acute-phase response were correlated with the score for
intestinal cramps during running. The responses for the
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Table 3 Resting concentrations of IgG anti-LPS, IL-6, TNF-a,
CRP and pre-albumin in triathletes and untrained controls
Values are means‡S.E.M., with ranges given in parentheses. MU, median units.
Controls Triathletes P-value
IgG anti-LPS (MU/ml) 242‡28 146‡14 0.0013
(65–470) (15–288)
IL-6 (pg/ml) 1.1‡0.2 1.5‡0.3 0.3444
(0.7–6.5) (0.0–7.0)
CRP (lg/ml) 2.47‡0.34 1.53‡0.11 0.0033
(0.74–6.21) (0.54–3.61)
Pre-albumin (lg/ml) 322‡15 326‡7 0.8238
(200–494) (239–418)
Figure 3 CK response after the triathlon
Values are means‡S.E.M. Significant changes compared with the pre-race value
are indicated by aP! 0.05.
two athletes who abandoned the race because of GI
problems were similar to those of athletes with few or no
GI complaints.
There was no correlation between the highest LPS
concentration and the highest IL-6 concentration in each
athlete [Spearman rank correlation coefficient (r
s
) 0.039;
P fl 0.84]. However, there was a correlation, albeit weak,
between the highest IL-6 and CRP concentrations (r
s
0.442; P fl 0.016) and between the LPS and CRP concen-
trations (r
s
0.389; P fl 0.037).
Reference values were obtained from healthy untrained
control subjects for anti-LPS, IL-6, pre-albumin and
CRP (Table 3). Compared with this control group, the
athletes had lower concentrations of anti-LPS and CRP
at rest (Table 3). No differences were observed in IL-6
and pre-albumin concentrations.
Plasma CK concentrations were significantly elevated
after exercise, and continued to increase in the first
1 h after the race (Figure 3). This increase, however, was
not correlated with changes in the IL-6 concentration
(r
s
0.174; P fl 0.366). Similarly, no correlation was found
between CK and changes in TNF-a concentration (r
s
fi0.139; P fl 0.473), between CK and changes in CRP
concentration (r
s
0.363; P fl 0.053), or between CK and
changes in pre-albumin concentration (r
s
0.244; P fl
0.220).
DISCUSSION
The majority of the athletes in the present study (93%)
reported GI symptoms, and two athletes had to abandon
the race because of severe GI distress (vomiting and
diarrhoea). Such GI problems are often reported by
endurance athletes during long races, especially in the
heat and when running is involved [12–14]. Several of
those symptoms are also seen in patients with endo-
toxaemia, i.e. dizziness, nausea and vomiting during
and after the race. Indeed, elevated LPS levels were de-
tected after the race in many athletes (68% immediately
post-race and 79% after 16 h). However, only mild endo-
toxaemia was observed in the athletes (i.e. LPS just
above the 5 pg}ml threshold used to define endotoxaemia),
the degree of endotoxaemia was not correlated with the
incidence or the severity of the complaints, and there was
no correlation between LPS and IL-6 concentrations,
whereas the cytokine response (especially the IL-6
concentration) was correlated with severe complaints
(diarrhoea and vomiting). It may then be questioned
whether LPS does play a role in the occurrence of the GI
complaints. However, the absence of a direct correlation
between LPS and IL-6 concentrations is not surprising,
and does not imply that these parameters are not related.
For instance, intravenous injection of a bolus of LPS into
human volunteers resulted in a very transient peak of LPS
in the circulation, varying between 7 and 13 pg}ml, but
also resulted in maximal TNF-a levels of 68–1374 pg}ml
and IL-6 levels of 72–2820 pg}ml [23]. A direct, linear
correlation between LPS, TNF-a and IL-6 concen-
trations is therefore unlikely to be obtained in vivo, but
this does not exclude the possibility of a relationship
between them.
The degree of endotoxaemia observed in the present
study may seem mild, but if one considers the previous
volunteer study [23], an LPS concentration of the same
order (approx. 10 pg}ml) and present very transiently
gave rise to the cytokine responses mentioned above, i.e.
fever, dizziness, leucocyte changes, etc. The finding of
such mild endotoxaemia in these extreme conditions is
seemingly in contrast with two other studies [16,18],
which reported a high incidence of extreme endotoxaemia
in athletes participating in a 90 km run (Comrades
Marathon) and a long-distance triathlon respectively. In
the study by Brocke-Utne et al. [16], 81% of the athletes
had LPS levels above 100 pg}ml, whereas in the present
study the highest measured LPS level was 15 pg}ml. One
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explanation for the discrepancy may be the fact that the
athletes studied by Brocke-Utne et al. [16] were exhaus-
ted runners who had to abandon the race because of GI
complaints, dehydration and heat shock, whereas in the
present study 86% of the participants were able to finish
the race. However, similar observations were made by
Bosenberg et al. [18], who studied 18 triathletes and
observed that plasma LPS concentrations rose from a
mean of 81 ng}ml to 294 ng}ml. It must be kept in mind,
however, that the reported resting LPS concentrations in
those studies were already higher than those observed
in critically ill septic patients, which raises doubt about
the validity of the results. Analytical differences are likely
to be responsible for the discrepancies between the two
previous studies [16,18] and the present study. When an
LPS assay similar to the one used in the present study was
performed by Camus et al. [21], the results were in
agreement with ours. In that study very mild endo-
toxaemia (between 5 and 14 pg}ml) was observed after a
marathon in eight out of 18 athletes, whereas one athlete
had a high LPS level of 72 pg}ml [24].
The analysis of LPS in plasma is critically dependent
upon several factors, which may be responsible for the
discrepancies between the findings in the present study
and those of Brocke-Utne et al. [16] and Bosenberg et al.
[18]. LPS is usually determined with the LAL assay
[27,28]. This assay is based on the property of LPS to
activate the clotting cascade which is present in the
circulating cell (amoebocyte) of Limulus polyphemus,
the horseshoe crab. With this assay it is possible to de-
tect very low levels of LPS in plasma (3 pg}ml or 0.036
endotoxin units}ml), which is essential because endo-
toxaemia in humans is considered to be present at LPS
concentrations above 5 pg}ml [17]. A first critical point is
that plasma contains inhibitory substances that have to be
removed before the LPS assay. A dilution and heating
procedure is usually the method of choice [29]. Details of
the method to remove the inhibitory activity in plasma
are not always indicated [16,18]. Secondly, the reference
ranges in the other studies [16,18] are rather high, i.e.
between 64 and 100 pg}ml, and would therefore be
within the range observed in septic patients using other
assays. Thirdly, the LAL reagent not only may react to
LPS, but may also be sensitive to b-glucan. b-Glucan is
present in fungi, and can be found in the membranes used
in kidney dialysis and cardiobypass apparatus [29]. In the
present study both a b-glucan-insensitive and a more b-
glucan-sensitive LPS assay were used. Immediately after
the race, the b-glucan-sensitive assay gave higher levels of
LPS than the b-glucan-insensitive assay. This could
indicate that fungal material, also likely to originate from
the intestine, is present in the circulation at that time. It is
unclear whether the LAL in the other two studies [16,18]
was glucan sensitive, but the two assays we used, from
different companies, both indicated low levels of endo-
toxaemia.
Another method for investigating whether LPS has
appeared in the circulation is to measure the plasma anti-
LPS concentration. In a study in racehorses, the IgG
anti-LPS concentration was significantly reduced after a
race [19]. Also, both the pre- and post-race IgG anti-LPS
levels were lower than the values measured in untrained
horses, which could indicate that training and com-
petition lead to leakage of LPS into the circulation and a
subsequent increase in specific antibody production [18].
Similarly, serum IgG anti-LPS concentrations were
negatively correlated with the LPS concentration in the
circulation in long-distance runners [16]. We observed
40% lower IgG anti-LPS levels in our trained subjects
compared with untrained controls, which may also be
due to some LPS leakage during training sessions in the
weeks preceding the race. The observed decrease in IgG
anti-LPS at 16 h after the triathlon suggests that there is
a continuous leakage of LPS into the circulation in the
first few hours after this extreme exercise.
Blood monocytes and tissue macrophages secrete
several cytokines, such as TNF-a and IL-6, upon
activation by LPS [30]. In the present study the TNF-a
concentration did not change and was barely detectable
above the lower detection limit of the assay (0.5 pg}ml),
which is in agreement with some [31,32], but not all [24],
previous studies. Northoff and Berg [31] and Rohde et al.
[32] were unable to detect TNF-a in subjects on
completion of a marathon and a triathlon respectively.
The finding that TNF-a levels were low (i.e. just above
the detection limit) and were not observed to increase is
not surprising if one considers the much more serious
condition of sepsis. In studies involving 97–146 patients
with sepsis, only 4–54% of the patients had detectable
levels of TNF-a in the circulation [33]. This may be due
to the rapid clearance of TNF-a from the circulation [33],
and the sensitivity of the assays in use at the time. Our
findings are in contrast with those of Camus et al. [21],
who reported a 2-fold increase in TNF-a levels following
a marathon, but the initial values of 10 pg}ml reported
before the race make these data difficult to interpret.
Increased IL-6 levels were demonstrated in 28 of the 29
athletes in the present study, which confirms obser-
vations by other investigators after various exercise
conditions [34], including a marathon [24]. This may, at
least partly, be due to the endotoxaemia occurring during
and after the triathlon, but the possibility cannot be
excluded that the elevated IL-6 levels were also partly due
to the exercise itself or to muscle damage. Bruunsgaard et
al. [35] recently showed that IL-6 concentrations were
significantly increased after 2 h of eccentric exercise, but
not after 2 h of concentric exercise, and that the IL-6
concentration was significantly correlated with the
CK concentration as a parameter of muscle damage. The
athletes in the present study encountered a fair amount of
downhill running and thus eccentric exercise. However,
in the present study we could not find a correlation
# 2000 The Biochemical Society and the Medical Research Society
54 A. E. Jeukendrup and others
between the cytokine}acute-phase responses and plasma
CK.
IL-6 is one of the main stimuli of the acute-phase
reaction. CRP, a participant of the positive acute-
phase reaction, and pre-albumin, representing the nega-
tive acute-phase reaction, were markedly increased and
decreased respectively in the samples collected 16 h after
the race. Also, a positive correlation was obtained
between the maximum IL-6 and CRP concentrations (r
s
0.442; P fl 0.016). Elevations of positive acute-phase
proteins have been reported by others [36–39]. Dufaux et
al. [36] and Liesen et al. [37] reported 6-fold increases in
CRP 1 day after a 2 h or a 3 h run respectively, while a
peak may be observed 24 h after strenuous exercise [39].
Castell et al. [38] reported a 4-fold increase in CRP levels
16 h after a marathon. These results seem to be in
agreement with those of the present study, in which we
found CRP to be increased 20-fold and pre-albumin to be
decreased by 12% 16 h after the race.
In conclusion, mild systemic endotoxaemia was
observed in some athletes in the hours after strenuous
exercise. Also, anti-LPS levels were significantly
decreased 16 h after exercise, suggesting that there was
portal vein endotoxaemia during and after exercise. There
was no linear correlation between the extent of systemic
endotoxaemia and the severity of GI complaints or the
IL-6 response. This suggests that systemic endotoxaemia
is not a direct cause of GI complaints, but the absence of
a correlation does not necessarily exclude a relationship
between these parameters. There was a clear cytokine
response immediately after exercise and a clear acute-
phase response on the day after exercise, and both of
these were positively correlated with some of the severe
GI complaints (e.g. diarrhoea, vomiting) during exercise.
As both responses may, at least partly, have been due to
the systemic and portal vein endotoxaemia, we conclude
that the gut barrier function for bacterial endotoxins and
potentially also for fungal b-glucans may be lost during
severe prolonged exercise, and this may lead to GI
complaints. However, the possibilty cannot be excluded
that other exercise-induced processes, e.g. muscle dam-
age, also play a role in cytokine and acute-phase
activation.
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